Pelubiprofen

• CAT Number: I008631
• CAS Number: 69956-77-0
• Molecular Formula: C16H18O3
• Molecular Weight: 258.32
• Purity: ≥95%
• Synonyms: Pelubiprofen; CS-670; DW-330; RS-2131; CS 670; DW 330; RS 2131; CS670; DW330; RS2131; Pelubi;(E)-2-(4-((2-oxocyclohexylidene)methyl)phenyl)propanoic acid
• Target: COX
• Solubility: Soluble in DMSO
• Storage: 0 - 4 °C for short term, or -20 °C for long term
• IUPAC Name: 2-[4-[(E)-(2-oxocyclohexylidene)methyl]phenyl]propanoic acid
• InChI: InChI=1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+
• InChIKey: AUZUGWXLBGZUPP-GXDHUFHOSA-N
• SMILES: CC(C1=CC=C(C=C1)C=C2CCCCC2=O)C(=O)O

Pelubiprofen(CAT: I008631) is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase (COX), reducing the production of prostaglandins responsible for inflammation, pain, and fever. It is widely used in pharmaceutical and clinical research to study its efficacy in managing conditions such as osteoarthritis, rheumatoid arthritis, and musculoskeletal pain. Known for its improved gastrointestinal tolerability compared to traditional NSAIDs, Pelubiprofen provides insights into COX inhibition and its therapeutic potential. This compound is a valuable tool for advancing research into inflammation and pain management, contributing to the development of safer and more effective anti-inflammatory therapies.